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Simple Summary: Weaning is a stressful event for piglets reared under commercial conditions, 
often resulting in economic losses due to reduced animal performance and health. The growing 
discouragement of antibiotic applications under these circumstances has stimulated the search for 
alternatives, like plant-derived products, to sustain piglet health. Thymol, the main compound in 
thyme essential oil, is considered as a valid alternative, mainly due to its antimicrobial properties. 
However, upon ingestion thymol quickly disappears from the upper gastro-intestinal tract, so that 
the concentrations remaining in the distal small intestine are far too low to kill off undesired bacteria. 
We tested gluco-conjugation, the linkage of a compound with a glucose unit, as a protective measure 
to obtain elevated thymol concentrations in the gut. Therefore, weaner piglets were fed a basal diet 
either un-supplemented or supplemented with pure thymol or its gluco-conjugate, thymol α-D-
glucopyranoside. Neither treatment could change the microbial composition. Nevertheless, thymol 
reduced diarrhea incidence and improved intestinal integrity, while thymol α-D-glucopyranoside 
did not. To conclude, gluco-conjugation insufficiently protected thymol from fast absorption and 
negated the positive physiological effects of thymol, indicating that further research is warranted. 
Abstract: The present study evaluated gluco-conjugation as a measure to delay thymol absorption 
and enhance its antimicrobial activity in the gut of weaned piglets. The three dietary treatments 
consisted of a basal diet without additives (TCON), supplemented with thymol at 3.7 mmol/kg dry 
matter (TTHY), or with an equimolar amount of thymol α-D-glucopyranoside (TTαG). Each dietary 
treatment was replicated in 6 pens with 2 piglets per pen (n = 12 for analytical parameters) and was 
supplemented for 14 days. The total (free plus gluco-conjugated) thymol concentrations in the 
stomach contents were 14% lower in TTαG as compared to TTHY piglets. Neither of the additives could 
be detected further down the gut. E.coli counts in the proximal small intestine were significantly 
lower in TTHY than in TTαG pigs (3.35 vs. 4.29 log10 CFU/g); however, other bacterial counts and their 
metabolites were unaffected by treatment. A metagenomic bacterial analysis revealed a great 
relative abundance of Lactobacillus spp. in the distal small intestine (range 88.4%–99.9%), irrespective 
of treatment. The intestinal barrier function was improved by TTHY, but not TTαG, compared to TCON. 
In conclusion, gluco-conjugation did not result in higher thymol concentrations in the gut, but 
conversely, it seemed to diminish the biological effects of thymol in vivo. 
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1. Introduction 
The common practice of early weaning (usually around 3–5 weeks of age) in commercial pig 
production subjects the immature piglets to a variety of stressors caused by alterations in the social 
structure, diet, and environment [1]. Therefore, weaning negatively impacts piglet health, 
performance, and sometimes survival rates, which eventually results in heavy economic losses [2]. 
Because many countries are now restricting the use of antibiotics and pharmacological zinc oxide in 
animal production [3–5], there is a growing need for cost-effective alternatives to control post-
weaning diarrhea and improve the performance of weaned piglets. 
Phytogenic feed additives are widely recognized as promising candidates to replace in-feed 
antibiotics [6]. They are mainly engaged to stabilize the gastro-intestinal (GI) functions with the 
ultimate goal to improve animal performance [7]. One of the most frequently investigated functional 
phytochemicals is thymol, the main monoterpene phenol in the essential oil (EO) extracted from 
thyme, which possesses antimicrobial, anti-oxidative, and anti-inflammatory properties [8]. These 
features make thymol a promising bioactive substance for application in animal feed, but the 
implementation still encounters some challenges [9]. Although EOs are mainly applied for their 
antimicrobial effects [6], the recommended doses of commercially available products are far below 
the required minimal inhibitory concentrations (MIC) for the modulation of gut microbiota [10,11]. 
Moreover, the lipophilic nature of EOs, including thymol, impedes the effective delivery of the active 
compounds to the gut, due to their fast and almost complete absorption in the stomach and proximal 
small intestine [12]. Increasing inclusion levels in the diet is not recommended with regard to cost-
effectiveness [9], reduced palatability [13], and possible toxic effects [14]. Therefore, it is vital to find 
proper protection methods in order to obtain adequate antimicrobial concentrations in the distal 
small intestine, where most diarrhea-causing enterotoxigenic Escherichia coli reside [15]. 
Glyco-conjugation is a process that naturally occurs in plants to increase the water solubility and 
stability of secondary metabolites and to alter their functionality [16]. Moreover, the potential of 
glycoside prodrugs has been explored in human medicine as well [17]. However, when orally 
administering these glyco-conjugates, hydrolysis in the GI tract should take place to release the active 
aglycon [17]. Based on ex vivo tests with everted porcine jejunal segments, Petrujkić et al. (2013) [18] 
concluded that thymol β-D-glucopyranoside (TβG) was more resistant to intestinal absorption than 
its aglycon, thymol. Although we were unable to demonstrate the delayed absorption of TβG or its 
stereo-isomer thymol α-D-glucopyranoside (TαG) after supplementing piglets for one day in our 
previous experiment [19], it still remains to be elucidated what the long-term effects of TαG 
supplementation are. Indeed, the absorbed thymol might display beneficial effects via the systemic 
route or it might exert topical action on the epithelial mucosa, where it has been shown to accumulate 
[20,21]. Furthermore, gluco-conjugation has the additional advantage of reducing the volatility [22] 
and masking the pungent taste of thymol [23]. Therefore, this research investigated whether the long 
term supplementation of weaned piglets with TαG could increase the luminal thymol concentrations 
in the small intestine. Furthermore, we aimed to elaborate on the effects of this TαG supplementation 
on the performance, small intestinal barrier function, and gut microbiota composition, as compared 
to un-supplemented or thymol-fed animals. 
2. Materials and Methods 
2.1. Animals and Housing 
The study was conducted in accordance with the ethical standards and recommendations for 
accommodation and care of laboratory animals covered by the European Directive (2010/63/EU) on 
the protection of animals used for scientific purposes and by the Belgian royal decree (KB29.05.13) on 
the use of animals for experimental studies. The experiment did not involve interventions causing 
harm equivalent to, or higher than, that caused by the introduction of a needle in accordance with 
good veterinary practice, and because animals were killed solely for the use of their organs or tissues 
(2010/63/EU). Moreover, electronarcosis followed by exsanguination is an approved method for 
euthanasia for this animal species. For this experiment, 36 piglets (Topigs hybrid × Piétrain) were 
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selected from 12 litters of a commercial farm. At weaning (28 days of age), three healthy, median 
weight piglets (range 6.5 ± 1.5 kg) were selected from each litter. Both castrated males and females 
were included. The selected piglets were transported to the trial facilities, where they were housed 
per two per pen (2.10 m2/pen) on full slatted floors. Until d5 post-weaning, the ambient temperature 
in the stable was kept at 30 °C with 24 h light. From d6 till d15, the ambient temperature was linearly 
adjusted to 28 °C with a 18L:6D light schedule. The animals had ad libitum access to feed and water 
at all times. The basal diet, from which the three experimental diets were derived, was wheat and 
barley based and formulated to meet or exceed recommendations by the Dutch Centraal 
Veevoederbureau [24]. More details about the composition of the diet can be found in Error! 
Reference source not found. The nutrient composition was analyzed according to the methods 
described by Spranghers et al. (2018) [25]. 
Table 1. Ingredient and analyzed nutrient composition of the basal diet (g/kg as fed). 
Compounds Amount Compounds Amount 
Ingredient Composition Calculated Nutrient Composition 
Wheat 297 NEv for pigs (MJ/kg) 10.0 
Barley 250 Digestible 2 Lysine 11.4 
Corn 150 Digestible 2 methionine + cysteine  6.8 
Soybean meal 76 Digestible 2 threonine 7.4 
Whey powder 53 Digestible 2 tryptophan 2.4 
Toasted soybeans 50 Calcium 6.6 
Sunflower meal 31 Digestible phosphorus 3.1 
Potato protein 30 Sodium 2.9 
Soybean oil 23 Potassium 7.1 
Limestone (fine) 11 Chlorine 4.0 
Sodium bicarbonate 5.6 Magnesium 1.4 
Dicalcium phosphate 5.3   
Premix minerals and vitamins 1 5   
Salt 2.0 Analyzed Nutrient Composition 
L-Lysine 5.4 Dry matter 896 
L-Threonine 2.3 Crude ash 47 
DL-Methionine 1.9 Crude protein 174 
L-Valine 1.1 Crude fat 55 
L-Tryptophan 0.7 Crude fibre  36 
Phytase (10,000 FYT/g) 0.1   
1 Providing per kg of diet: vit A (retinyl acetate), 10,000 IU; vit D3 (cholecalciferol), 2000 IU; vit E (dl-
a-tocopherol), 40 mg; vit K3 (menadione), 1.5 mg; vit B1 (thiamin), 1.0 mg; vit B2 (riboflavin), 4.0 mg; 
vit B6 (pyridoxin hydrochloride), 1.5 mg; vit B12 (cyanocobalamin), 20 μg; niacin, 30 mg; D-
pantothenic acid, 15 mg; choline chloride, 150 mg; folic acid, 0.4 mg; biotin, 0.05 mg; Fe 
(iron(II)sulphate monohydrate), 100 mg; Cu (copper(II)sulphate pentahydrate), 20 mg; Zn 
(Zinc(II)sulphate monohydrate), 70.0 mg; Mn (manganese(II)oxide), 30 mg; I (potassiumjodate 
anhydrate), 0.7 mg; Se (sodium selenite), 0.25 mg; 2 expressed as apparent ileal digestibility. 
2.2. Experimental Design and Measurements 
The experiment comprised three dietary treatments: the basal diet without additives (TCON), 
supplemented with thymol (TTHY) at 3.7 mmol/kg dry matter (DM; equivalent to 3.3 mmol/kg or 500 
mg/kg as fed), or with an equimolar amount of thymol α-D-glucopyranoside (TTαG). The experimental 
diets were prepared by dividing one batch of basal diet in three equal parts and mixing the 
appropriate amounts of the additives into the feed. Thymol was a crystalline powder and could be 
mixed into the feed as such, while TαG was mashed with a mortar to obtain a fine granular product 
prior to mixing. No carriers or other protection methods, like coating, were used. Subsamples of each 
diet were gathered immediately after mixing and stored at −20 °C for the analytical verification of the 
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additives. Thymol (CAS: 89-83-8; purity: 99.5%) was obtained from Sigma Aldrich (Bornem, 
Belgium). TαG (79% purity, 0.6% free thymol, 3.5% thymol diglucoside) was enzymatically 
synthesized according to the procedure described in De Winter et al. (2015) [26] from a reaction 
mixture containing thymol (5 g/L), sucrose (1 mol/L), and facilitated by the R134A mutant of 
Thermoanaerobacterium thermosaccharolyticum sucrose phosphorylase (4 U/mL).  
Treatments were replicated in six pens with two piglets per pen. First, piglets were allocated to 
the pens in order to stratify for mean body weight and litter origin. Therefore, three littermate piglets 
were assigned to three neighboring pens, and this was repeated with three piglets from a second 
litter. This process was repeated six times. Next, the filled 18 pens were assigned to the three 
treatments according to a randomized block design, where each treatment was randomly assigned 
to two pens per block. In this way, every treatment included six males and six females originating 
from 12 sows (Figure S1). The piglets were weighed individually on d0, d5, and d13 post-weaning. 
The feeders were weighed daily to determine the feed intake at the pen level. The average daily gain 
(ADG), average daily feed intake (ADFI), and feed:gain ratio (F:G) were calculated for the periods 
d0–5, d5–13, and d0–13 post-weaning. The same trained animal caretaker inspected the animals daily 
for general health, fecal consistency, and diarrhea incidence. The fecal consistency score was visually 
assessed on the pen level according to the following scoring system: 1 = hard or slightly moist feces, 
clearly formed, normal; 2 = moist or soft feces, but still with a definite form, sticky; and 3 = watery or 
liquid feces, unformed, diarrhea. The assessment of diarrhea incidence was done simultaneously by 
counting the piglets in a pen receiving a fecal score of 3 that showed clear signs of diarrhea, i.e., filthy, 
wet backside and tail, dehydrated, loss of condition, and irritation of the skin around the anus. The 
incidence was calculated at the pen level as the number of times a fecal score of 3 was given over the 
whole trial divided by the number of ‘animal days’ (i.e., number of animals in a pen (2) multiplied 
by the number of days that they were present (13)).  
2.3. Sample Collection 
The sample collection was spread over three days (d13-15 post-weaning) for practical reasons. 
Per sampling day, 12 piglets (four per treatment) were brought to electronarcosis followed by 
exsanguination. The entire GI tract was removed, exposed, and partitioned in the following six 
compartments for digesta collection: stomach, three parts of the small intestine (SI1, SI2, and SI3 
corresponding to segments of 0%–25%, 25%–75%, and 75%–100% of the total length, respectively), 
caecum, and mid-colon. The contents of each compartment were quantitatively collected and stirred 
well. A fresh aliquot (approximately one gram) of SI1 and SI3 was processed for bacteriological 
plating. Next, two digesta subsamples were taken from every compartment. The first was acidified 
to pH < 2 with 2% of 6 M H2SO4 to stop fermentation and stored at −20 °C pending an analysis of 
active compounds and bacterial metabolites. The second subsample was snap frozen in liquid 
nitrogen and stored at −80 °C for the determination of the glycosidase activity. A last aliquot of SI3 
digesta was collected in a sterile tube, snap frozen, and stored at −80 °C to determine the bacterial 
composition. The remaining digesta were frozen and freeze-dried for the determination of the dry 
matter contents. Meanwhile, a first 5 cm section of the small intestine was obtained at 75% (distal 
jejunum) of the total length, rinsed with 0.9% saline, and fixated in a 4% formaldehyde solution for a 
histo-morphological analysis. A second segment (20 cm) was obtained at 75% to assess the 
macromolecular permeability in the Ussing chambers (only the first two sampling days for practical 
reasons). Finally, a third segment (20 cm) was collected at 2.5% (duodenum), 25% (proximal jejunum), 
and 75% for its mucosa, harvested by gently scraping the mucosal surface with a glass slide, and was 
stored at −80 °C pending an analysis of the glycosidase activity.  
2.4. Laboratory Analysis 
2.4.1. Concentrations of Active Compounds in Digesta 
The concentration of the active compounds, thymol, and TαG in digesta samples of different GI 
compartments was determined as described by Van Noten et al. (2020) [19]. The samples were 
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extracted in ethyl acetate, 1-butanol, and 1-propanol (60:30:10; v/v/v) containing 2-isopropylphenol 
(0.25 g/L) and 4-nitrophenyl α-D-glucopyranoside (0.05 g/L) as internal standards for thymol and 
TαG, respectively. The organic phase was evaporated to dryness under nitrogen gas, and the residue 
was reconstituted in a mixture of water and acetonitrile (65:35; v/v). The extracted samples were 
subjected to an HPLC analysis with an elution gradient on a reversed phase C18 column and with 
the detection of the active compounds at 280 nm. 
2.4.2. Small Intestinal Barrier Function and Histo-Morphology 
The intestinal permeability was assessed using the Ussing chamber technique, as previously 
described by Wang et al. (2016) [27]. In brief, the segment of the distal jejunum was rinsed with saline, 
stripped from its outer muscle layers, slit longitudinally, and mounted into inserts with an exposed 
tissue area of 1.07 cm². Two replicate chambers were used per pig, and the tissues were mounted 
within 10 min post-mortem. Fluorescein isothiocyanate–dextran 4-kDa (FD4; Sigma-Aldrich, Bornem, 
Belgium) and horseradish peroxidase 40-kDa (HRP; type IV; Sigma-Aldrich) were used as 
macromolecular probes. The markers were added to the mucosal side after 20 min of equilibration to 
obtain final concentrations of 0.8 mg/mL and 0.4 mg/mL, respectively. Samples were taken from the 
serosal side every 20 min between 40 min and 100 min after mounting the segments. The fluorescent 
signal of FD4 was captured using an excitation filter at λ = 494 nm and an emission filter at λ = 521 
nm. An analysis of the HRP activity was performed, as described by McKie et al. (1999) [28], but the 
measurement was performed in a kinetic way (10 cycles, 1-min interval). 
The histo-morphological parameters villus height (VH) and crypt depth (CD) were determined 
according to standard procedures including dehydration, embedding in paraffin, and mounting of 5 
μm transverse sections on glass slides [29]. After staining with hematoxylin-eosin, the VH and CD 
were measured in at least 10 well-oriented villi and adjacent crypts using an Olympus BX61 
microscope and image analysis software (analySIS Pro, Olympus, Aartselaar, Belgium). VH:CD was 
calculated as the mean value of the ratios of the obtained villus heights and adjacent crypt depths. 
2.4.3. Bacteriological Analyses 
The bacterial counts (viable counts; log10 CFU /g fresh digesta) in the digesta of SI1 and SI3 were 
obtained using the ring-plate technique [30]. Seven serial 10-fold dilutions were made from 1 g of 
fresh digesta in a sterilized peptone solution (peptone, 1 g/L; agar, 0.4 g/L; NaCl, 8.5 g/L; and cysteine, 
0.7 g/L) and plated onto selective media for counting the following bacterial groups: lactobacilli 
(Rogosa Agar, CM0627B, Oxoid, Basingstoke, UK; incubated for 48 h at 37 °C under anaerobic 
conditions), total anaerobic bacteria (Reinforced Clostridial Agar, CM0151B, Oxoid; incubated for 48 
h at 37 °C anaerobic conditions), Escherichia coli (Tryptone Bile X-Glucuronide Agar, CM0945B, Oxoid; 
incubated aerobically for 24 h at 37 °C), coliform bacteria (Eosin Methylene Blue Agar, CM0069B, 
Oxoid; incubated aerobically for 24 h at 37 °C), and streptococci (Slanetz & Bartley Medium, 
CM0377B, Oxoid; incubated aerobically for 48 h at 37 °C).  
Bacterial metabolites were determined in the digesta of SI3 and the mid-colon. The volatile fatty 
acids (VFA) and lactic acid in the small intestinal contents were analyzed simultaneously as described 
by Missotten et al. (2009) [31]. Briefly, 2-ethyl butyric acid was added to the acidified samples as an 
internal standard. The mixture was extracted with diethyl ether, followed by derivatization with N-
tert-butyldimethylsilyl-N-methyltrifluroacetamide and a subsequent analysis on GC. A VFA analysis 
of mid-colon samples was performed on GC after extraction with 10% formic acid with ethyl butyric 
acid as the internal standard, as described by Castro-Montoya et al. (2012) [32]. The lactic acid content 
in the digesta from the mid-colon was quantified according to the microdiffusion method of Conway 
(1957) [33]. In short, lactic acid is oxidized by cerium to acetaldehyde, which then reacts with semi-
carbazide to form a semi-carbazon. The latter is measured with a spectrophotometer at 224 nm. 
The microbial composition analysis was performed by 16S ribosomal RNA (rRNA) profiling in 
the SI3 digesta. First, genomic DNA was extracted using PSP Spin Stool DNA Plus Kit (Invitek, 
Westburg, Netherlands) according to the manufacturer’s instructions. Next, the 16S polymerase chain 
reaction (PCR) libraries were generated and processed as described by Cong et al. (2019) [34]. In short, 
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the V1-V3 hypervariable region of the bacterial 16S rRNA was amplified using (5′-
GAGAGTTTGATYMTGGCTCAG-3′) and (5′-ACCGCGGCTGCTGGCAC-3′) as forward and reverse 
primers, respectively. After purification, amplicons were sequenced on the Illumina Miseq platform 
(Illumina, San Diego, USA) with the V3 chemistry kit. The obtained sequences were processed using 
MOTHUR (software package v1.39.5) for alignment and clustering [35], while the VSEARCH 
algorithm [36] was utilized for chimera detection. The final reads were clustered in operational 
taxonomic units (OTU) with a distance unit cut-off of 0.03. The SILVA database (v1.28) of full-length 
16S rRNA sequences [37] served as the basis for reference alignment and taxonomical assignment 
using the BLASTN algorithm. Originally, 6,567,253 raw reads were obtained. After cleaning for 
length and sequence quality, 6,204,369 reads remained, and the removal of chimeric contaminants 
resulted in 6,059,497 reads (49,734–287,387 reads per sample). Subsampled datasets of 10,000 reads 
per sample were utilized for further analysis. The alpha diversity was evaluated with MOTHUR at 
the genus level by calculating the Chao1 richness index (richness), reciprocal Simpson biodiversity 
index (diversity), and Simpson evenness index (evenness). All raw reads of small intestinal digesta 
samples have been deposited at the National Center for Biotechnology Information (NCBI) and are 
available under the BioProject ID: PRJNA603645. 
2.4.4. Glycosidase Activity in Mucosa and Digesta 
Prior to the quantification of the glycosidase activity in mucosa, phosphate buffered extracts 
were made. Therefore, one gram of mucosa was homogenized with 5 mL ice-cold phosphate buffered 
saline (PBS) (0.1 mol/L, pH 7.0) using an Ultra Turrax T25 (IKA) at 9500 rpm for 30 s. The mixture 
was centrifuged (15,000× g, 15 min, 4 °C), and the supernatant was divided into small portions and 
stored at −80 °C until analysis. During the extraction process, samples and supernatants were kept 
on ice all the time to prevent enzyme degradation. The glycosidase activity was determined 
spectrophotometrically by measuring the appearance of p-nitrophenol (pNP) after the hydrolysis of 
its respective p-nitrophenyl glycoside. Three activities were evaluated: α-glucosidase (αGLU), β-
glucosidase (βGLU), and β-galactosidase (βGAL). All substrates (p-nitrophenyl α-D-
glucopyranoside (EN03227), p-nitrophenyl β-D-glucopyranoside (EN03181) and p-nitrophenyl β-D-
galactopyranoside (EN06672), respectively) were purchased from Carbosynth Ltd., Compton 
Berkshire, UK. Substrates were dissolved in PBS, and the resulting stock solutions (13.3 mmol/L) were 
pre-incubated at 37 °C. The final reaction mixtures (pH 7.0) were prepared in 96-well plates by mixing 
1 volume of supernatant with 3 volumes of the appropriate substrate. The well-plate was 
immediately transferred to the absorbance reader (Tecan Infinite M Nano) where the release of pNP 
was determined at 405 nm and at 37 °C during nine kinetic cycles with an interval of 90 s. All samples 
were analyzed in triplicate.  
Digesta homogenates were prepared in a similar way (except: 1 g sample in 4 mL PBS), but an 
extra filtration step of the supernatants over a paper filter (particle retention: 12–15 μm) was 
performed. The stock solutions contained 20 mmol pNP-substrate/L, and the reaction mixture was 
obtained by mixing 1 volume of substrate solution with 1 volume of supernatant. A standard curve 
of pNP dissolved in the same PBS buffer (pH 7.0) was used to calculate the glycosidase activity, which 
was expressed in units, with one unit (U) corresponding with 1 mmol of pNP released per min per g 
protein or with 1 nmol of pNP released per min per g fresh matter, for mucosa and digesta, 
respectively.  
The bicinchoninic acid method [38] was used to determine the protein content of the mucosal 
extracts (sample to standard working reagent-ratio = 1:8; incubation: 30 min at 37 °C). The standard 
was bovine serum albumin. All chemicals were bought from Sigma Aldrich (Bornem, Belgium). 
2.4.5. Statistical Analysis 
The experimental unit for animal performances was the pen. The individual animal was 
considered the experimental unit for analytical variables. All statistical analyses, except for the 16S 
microbial composition data, were performed with SPSS statistics 25.0 program (SPSS Inc., Chicago, 
IL, USA). Assumptions of normality and equality of variances were checked using the Shapiro-
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Wilkinson and Levene’s test, respectively, before an analysis of the data by the general linear model 
(GLM) procedure with treatment as a fixed factor and block as a random factor, in combination with 
Tukey post-hoc tests. The blocking factor accounted for variability between litters and sampling days. 
In case of heteroscedasticity, the one-way ANOVA procedure with Welch correction was used in 
combination with Games-Howell post-hoc tests. In case the data were not normally distributed, 
Kruskal-Wallis non-parametric tests in combination with Dunn’s post-hoc tests were used. 
Concentrations of active compounds in digesta were subjected to t-tests to discern differences with 
feed concentrations. Differences were considered significant at p ≤ 0.05, and statistical tendencies 
were assumed when 0.05 < p < 0.10. The data are presented as least square means with SEM, unless 
stated otherwise. 
Statistical differences in microbial richness, diversity, and population evenness between the 
treatments on the genus level were investigated using the GLM procedure, with treatment as a fixed 
factor and block as a random factor. The microbial composition data were analyzed on the genus 
level with MOTHUR to assess the diversity clustering of dietary treatments with the Bray-Curtis 
matrix using the analysis of molecular variance (AMOVA) and the homogeneity of molecular 
variance (HOMOVA). The AMOVA test is a non-parametric analysis for testing the hypothesis that 
the genetic diversity within one treatment is not significantly different from the genetic diversity in 
all treatments together. The HOMOVA test is a non-parametric analysis used to test the hypothesis 
that the genetic diversity within the different treatments is homogeneous [39]. Statistical differences 
in relative bacterial abundances between treatments were tested by non-parametric Kruskal–Wallis 
tests with Tukey-Kramer post-hoc tests and the Benjamin–Hochberg false discovery rate using the 
STAMP software (Version 2.1.3) on the phylum, family, and genus levels. 
3. Results 
3.1. Animal Performance 
No animals had to be removed from the study, no mortality occurred during the experiment, 
and antibiotic treatments were limited to a few individual intramuscular injections. No significant 
differences were found in body weight (BW), ADG, ADFI, or F:G between the dietary treatments in 
any of the monitored periods post-weaning (Table 2). Piglets from the control treatment lost weight 
during the first 5 days post-weaning, whereas the supplemented groups displayed a slightly positive 
ADG in this period (p > 0.05). The ADFI did not differ significantly between treatments in any of the 
monitored periods post-weaning. However, piglets from treatment TTαG performed numerically the 
best as to BW, ADG, and ADFI during the whole experimental period (p > 0.05). On the other hand, 
there was a tendency (p = 0.082) for a lower F:G in TαG (−4.67) as compared to thymol (5.06) fed pigs 
from d0-5 post-weaning. However, this was due to two TTαG-pens which had a normal ADFI (62 and 
82 g), but a slightly negative ADG (−3 and −5 g, respectively). The diarrhea incidence was highest 
between d4 and d7 post-weaning (data not shown). The average fecal consistency score was 
significantly lower in thymol-fed piglets (1.53) as compared to control animals (1.81) on a scale from 
1 (firm) to 3 (watery), with an intermediate score for TαG-fed piglets (1.60). Moreover, there was also 
a tendency (p = 0.086) for a lower diarrhea incidence in TTHY (12.2%) as compared to TCON (24.3%). 
3.2. Concentrations of Active Compounds 
The analytically verified total thymol concentration measured in the feeds differed from the 
intended dose of 3.7 mmol/kg DM. TTHY feeds contained 2.4 mmol thymol/kg DM, while TTαG feeds 
included 3.0 mmol TαG /kg DM and 0.08 mmol thymol/kg DM (Figure 1). Further calculations were 
made with these actual concentrations. The thymol concentration in the stomach contents of TTHY pigs 
was 13% lower than in the feed (on DM basis) (p = 0.031). 
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Table 2. The effect of dietary treatment on the animal performance of piglets from d0 to d13 post-
weaning. 
 TCON 1 TTHY TTαG SEM p-Value 
Body Weight (kg) 
d0 6.52 6.52 6.52 0.23 0.999 2 
d5 6.24 6.56 6.59 0.10 0.294 
d13 8.11 8.41 8.56 0.17 0.550 
Average Daily Gain (g/d) 
d0-5 −46 7 12 13.7 0.199 
d5-13 234 231 246 14.1 0.894 
d0-13 114 135 146 11.8 0.550 
Average Daily Feed Intake (g/d) 
d0-5 62 79 87 9.0 0.539 
d5-13 262 274 295 17.2 0.741 
d0-13 185 199 215 13.4 0.673 
Feed:Gain 
d0-5 −0.88 5.06 −4.67 1.62 0.082 
d5-13 1.14 1.19 1.20 0.04 0.811 
d0-13 1.54 1.48 1.50 0.04 0.823 
Fecal Consistency 
Average Score 3 1.81 a 1.53 b 1.60 ab 0.20 0.038 
Diarrhea incidence (%) 24.3 12.2 20.3 2.1 0.086 
a,b Least square means within a row without a common superscript letter differ significantly (p ≤ 0.05). 
1 TCON: basal diet; TTHY: basal diet supplemented with 3.7 mmol thymol/kg DM; TTαG: basal diet 
supplemented with 3.7 mmol thymol-α-D-glucopyranoside/kg DM; n = 6. 2 Welch correction used. 
Calculated means are displayed. 3 Expressed on a scale from 1 (normal feces) to 3 (diarrhea). 
Furthermore, in the stomach contents of TTαG pigs only 37% of the thymol was present as gluco-
conjugate, while the remaining 63% was present in its free form. In addition, in the stomach the 
remaining total thymol concentration (sum of free and conjugated form) was only 58% of the feed 
concentration for the TTαG treatment (p < 0.001). Finally, the total thymol concentration was 
significantly lower in the stomach contents of TTαG piglets (1.78 mmol/kg DM) as compared to TTHY 
animals (2.10 mmol/kg DM), even though the actual concentration in the feed was lower in the TTHY 
treatment. The concentrations of both active compounds in the small intestine, caecum, and colon 
were below the detection limit and thus not quantifiable. 
 
Figure 1. The concentration of thymol and thymol α-D-glucopyranoside (TαG) in the feeds and 
stomach digesta of piglets fed an intended dose of 3.7 mmol/kg DM (vertical red line) of thymol (TTHY) 
or TαG (TTαG). 
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3.3. Small Intestinal Barrier Function and Histo-Morphology 
Supplementing thymol in the diet of piglets significantly reduced the jejunal permeability for 
FD4 with 56% as compared to the control treatment (Table 3). The permeability of HRP, on the other 
hand, was unaffected by treatment. Regarding the histo-morphological parameters, there was a 
tendency (p = 0.071) for an increased VH:CD ratio in TTHY when compared to TCON. This difference 
was not due to changes in the crypt depth, but could be explained by the numerically longer villi (p 
> 0.05). 
Table 3. The effect of dietary treatment on barrier function and histo-morphology in the distal 
jejunum of piglets between 13 and 15 days post-weaning. 
 TCON 1 TTHY TTαG SEM p-Value 
Apparent Permeability (*10-7cm/s)2 
FD4 3 6.54 a 2.88 b 6.32 ab 0.84 0.028 4 
HRP 3 3.02 0.67 1.31 0.47 0.143 4 
Histo-Morphology 2 
Villus Height (μm) 513 584 548 15 0.160 
Crypt depth (μm) 205 205 200 3 0.715 
Villus height:crypt depth 2.57 2.88 2.77 0.06 0.071 
a,b Least square means within a row without a common superscript letter differ significantly (p ≤ 0.05). 
1 TCON: basal diet; TTHY: basal diet supplemented with 3.7 mmol thymol/kg DM; TTαG: basal diet 
supplemented with 3.7 mmol thymol-α-D-glucopyranoside/kg DM; 2 n = 8 for permeability, n = 12 for 
histomorphology. 3 FD4 = fluorescein isothiocyanate–dextran 4-kDa; HRP = horseradish peroxidase 
40-kDa. 4 Welch correction used. Calculated means are displayed. 
3.4. Bacteriological Analyses  
3.4.1. Bacterial Counts 
The counts of different bacterial groups in the digesta of the proximal (SI1) and distal small 
intestine (SI3) are listed in Table 4.  
Table 4. The effect dietary treatment on bacterial counts (log10 CFU/g) in the small intestine of piglets 
between 13 and 15 days post-weaning. 
 TCON 1 TTHY TTαG SEM p-Value 
SI1 2 
Lactobacilli 7.38 7.36 7.46 0.09 0.898 
Total anaerobes 6.60 6.72 6.39 0.14 0.334 3 
E. coli 3.44 ab 3.35 b 4.29 a 0.16 0.041 
Total coliforms 4.21 3.33 3.81 0.22 0.267 
Streptococci 7.31 7.45 7.41 0.09 0.820 
SI3 
Lactobacilli 8.71 8.38 8.85 0.08 0.070 
Total anaerobes 7.53 7.07 7.44 0.09 0.069 
E. coli 5.51 5.26 6.22 0.17 0.078 
Total coliforms 5.48 5.22 6.21 0.17 0.069 
Streptococci 8.44 8.45 8.79 0.09 0.174 
a,b Least square means within a row without a common superscript letter differ significantly (p ≤ 0.05). 
1 TCON: basal diet; TTHY: basal diet supplemented with 3.7 mmol thymol/kg DM; TTαG: basal diet 
supplemented with 3.7 mmol thymol-α-D-glucopyranoside/kg DM; n = 12. 2 SI1 and SI3 correspond 
to segments of 0%–25% and 75%–100% of the total small intestinal length, respectively. 3 Welch 
correction used. Calculated means are displayed. 
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At the level of the proximal small intestine, the supplementation of thymol significantly reduced 
the numbers of E. coli with almost one log unit as compared with TαG (3.35 versus 4.29 log10 CFU/g, 
respectively). Other bacterial counts in the proximal small intestine remained unchanged. Similarly, 
no major changes in bacterial counts were induced by dietary supplementation in the distal small 
intestine. However, the numbers of Lactobacilli (p = 0.070), E. coli (p = 0.078) and total coliforms (p = 
0.069) tended to be lower in TTHY than in TTαG, while there was a trend (p = 0.069) towards lower counts 
of total anaerobes in thymol-supplemented groups as compared to control piglets. 
3.4.2. Bacterial Metabolites 
Concentrations of bacterial metabolites in the contents of the distal small intestine and mid-colon 
did not differ amongst treatment groups (Table 5). However, there was more of a tendency (p = 0.088) 
towards lower valerate percentages in the mid-colon of thymol-supplemented groups than in control 
groups. 
Table 5. The effect of dietary treatment on bacterial metabolites (μmol/g) in the small intestine and 
mid-colon of piglets. 
 TCON 1 TTHY TTαG SEM p-Value 
SI3 2 
Total Volatile Fatty Acids 6.44 7.47 5.65 0.63 0.504 
% Acetate 96.6 98.2 98.3 0.6 0.330 3 
% Propionate 3.2 1.3 1.5 0.6 0.132 3 
% Butyrate 0.3 0.6 0.2 0.1 0.349 3 
Lactate 53.45 42.42 61.30 5.04 0.320 
Mid-colon 
Total Volatile Fatty Acids 164.9 176.0 162.1 3.55 0.251 
% Acetate 53.7 55.4 55.0 0.7 0.505 4 
% Propionate 27.0 26.2 27.3 0.6 0.699 
% Iso-butyrate 1.0 1.1 0.7 0.1 0.182 
% Butyrate 13.2 13.3 12.4 0.4 0.703 
% Iso-valerate 1.4 1.5 1.2 0.1 0.254 4 
% Valerate 3.8 2.7 3.3 0.2 0.088 
Lactate 22.14 23.53 21.08 0.53 0.185 
1 TCON: basal diet; TTHY: basal diet supplemented with 3.7 mmol thymol/kg DM; TTαG: basal diet 
supplemented with 3.7 mmol thymol-α-D-glucopyranoside/kg DM; n = 12. 2 SI3 corresponds to a 
segment of 75%–100% of the total small intestinal length. 3 Kruskal-Wallis non-parametric test. 
Calculated means are displayed. 4 Welch correction used. Calculated means are displayed. 
3.4.3. Microbial Composition by 16S rRNA Profiling 
Due to insufficient intestinal material, only 10 samples (out of 12) of the TCON group could be 
sequenced. Additionally, one piglet from the TTHY group was removed from the dataset because of a 
deviating microbial profile (see piglet 22 in Figure S2). Thus, in total 33 16S metagenomic profiles 
were used (10 TCON, 11 TTHY, and 12 TTαG), in which 678 different OTUs were identified. No treatment 
effects were present on the alpha diversity of the communities in SI3 (Figure 2) as estimated by Chao1 
(p = 0.621), reciprocal Simpson (p = 0.551), and Simpson evenness indexes (p = 0.906). Additionally, 
the beta diversity analysis using AMOVA and HOMOVA did not reveal significant differences in the 
community composition between treatments (p = 0.166 and p = 0.341, respectively).  





Figure 2. The alpha diversity indices of the microbial community composition on the genus level in 
the small intestinal contents of the last 25% of the total length of piglets fed a basal diet (TCON) 
supplemented with 3.7 mmol/kg DM thymol (TTHY) or thymol α-D-glucopyranoside (TTαG) (a) 
bacterial richness (Chao1 richness index); (b) bacterial diversity (Reciprocal Simpson biodiversity 
index; and (c) bacterial evenness (Simpson evenness index). The data are represented as scatter plots: 
each dot represents a piglet, together with the mean (middle line) and SEM (whiskers). 
The cumulated relative abundances of the microbial community in SI3 at the phylum, family, 
and genus levels are represented in Figure 3, while the microbial community compositions at the 
same levels of each individual piglet are available in Figure S2. Across all diet groups, 10 phyla were 
identified, with Firmicutes being an extremely dominant phylum (98.1%–99.9% of the total 
sequences). The second largest phylum was Proteobacteria, accounting for 0.06%–1.89% of the 
sequences, and all the other phyla had a relative abundance below 0.01%. At the family level, it 
became evident that these Firmicutes are mainly represented by Lactobacillaceae and Clostridiaceae, 
accounting for 97.3%–99.6% and 0.2%–2.2% of the total sequences, respectively, while 
Enterobacteriaceae are the main family representing the Proteobacteria, with 0.06%–1.88% of the 
sequences. The other 52 identified families had relative abundances below 0.1%. The major genera 
were Lactobacillus (97.3%–99.6%), Clostridium_sensu_stricto_1 (0.2%–2.2%), and Escherichia-Shigella 
(0.05%–1.76%). Furthermore, the relative abundances of the remaining 119 identified genera were 
below 0.1%. Finally, Lactobacillus amylovorus was identified as the most abundant species, accounting 
for 91.9%–95.4% of all identified sequences. Other abundant species were an uncultured 
Lactobacillus_Otu00010 (2.4%–3.0%), Clostridium_sensu_stricto_1_DQ797692 (0.12%–2.05%), 
Escherichia coli (0.03%–1.68%), and Lactobacillus delbrueckii (0.24%–0.52%). No statistical differences 
were found among the treatments on the relative abundance of taxonomic groups at the phylum, 
family, or genus levels. Because the dominance of lactobacilli might have masked more subtle 
treatment-induced variations in other taxa, an attempt was made to remove those sequences 
identified as Lactobacillus on the genus level from the dataset before subsampling. Unfortunately, 
fewer than 10,000 sequences remained for the majority of the samples, and a large variation in the 
sequencing depth was created between samples, making a statistical analysis insufficiently reliable.  




Figure 3. The cumulated relative abundances of the identified taxa at the (a) phylum, (b) family, and 
(c) genus levels in the small intestinal contents of the last 25% of the total length of piglets fed a basal 
diet (TCON) supplemented with 3.7 mmol/kg DM thymol (TTHY) or thymol α-D-glucopyranoside (TTαG). 
3.5. Glycosidase Activity in Mucosa and Digesta 
The βGLU and βGAL activities in the duodenal mucosa were significantly reduced by 34% and 
30%, respectively, in thymol-supplemented piglets as compared to control animals (Table 6). This 
effect, however, did not persist more distally in the small intestine, nor was the αGLU activity affected 
by treatment. In the digesta, no treatment effects could be demonstrated for any of the measured 
glycosidase activities in either compartment. 
4. Discussion 
4.1. Effect of Thymol and TαG Supplementation on Pig Performance 
Although numerous trials have evaluated the effects of herbs and EO mixtures containing 
thymol on pig performance with variable outcomes [40–42], to our knowledge no data are available 
concerning the consequences of TαG supplementation. Additionally, only a limited amount of pig 
experiments reporting performance data have been carried out with pure thymol, and in none of 
these cases supplementation (range 67–10,000 mg thymol/kg feed) resulted in significantly increased 
ADG or final BWs [43–46]. This is in agreement with our findings, although thymol- and TαG-
supplemented piglets performed numerically better than the control in the current trial. 
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Table 6. The effect of dietary treatment on the glycosidase activity in the mucosa (mmol/min/g) and 
digesta (nmol/min/g) of piglets. 
 TCON 1 TTHY TTαG SEM p-Value 
Mucosa (mmol/min/g) 
α-Glucosidase 
Duodenum 0.84 0.87 0.87 0.03 0.863 
Proximal Jejunum 1.17 1.06 1.25 0.06 0.399 3 
Distal Jejunum 1.06 1.10 1.29 0.06 0.3503 
β-Glucosidase 
Duodenum 12.03 a 7.95 b 11.25 ab 0.62 0.027 
Proximal Jejunum 11.93 9.31 10.54 0.67 0.299 
Distal Jejunum 4.88 4.66 4.41 0.39 0.882 
β-Galactosidase 
Duodenum 18.93 a 13.25 b 17.68 ab 0.85 0.026 
Proximal Jejunum 21.23 17.59 18.40 0.95 0.276 
Distal Jejunum 14.39 15.70 18.59 1.06 0.269 
Digesta (nmol/min/g) 
α-Glucosidase 
Stomach 25.0 24.2 17.7 1.8 0.212 
SI12 113.1 67.4 113.2 11.5 0.190 
SI2 610.1 473.3 578.4 46.7 0.508 4 
SI3 1303.0 1097.5 1248.4 63.2 0.348 
Caecum 479.7 357.0 433.0 53.9 0.596 
Mid-colon 441.7 450.0 545.6 40.4 0.489 
β-Glucosidase 
Stomach 39.1 36.6 27.3 3.2 0.271 3 
SI1 325.0 290.3 319.8 38.9 0.926 
SI2 1276.1 1033.9 1153.7 124.8 0.643 4 
SI3 1852.5 1684.1 1942.5 202.2 0.863 
Caecum 674.8 564.8 663.2 98.8 0.650 4 
Mid-colon 838.1 585.8 512.1 81.3 0.280 3 
β-Galactosidase 
Stomach 22.6 22.2 19.8 2.0 0.829 
SI1 264.1 238.0 276.6 31.3 0.862 
SI2 1132.4 953.9 963.6 113.5 0.715 4 
SI3 1673.0 1396.6 1831.3 186.9 0.619 
Caecum 1341.0 1583.2 1715.3 246.9 0.818 
Mid-colon 1846.9 1815.6 2103.6 144.4 0.668 
a,b Least square means within a row without a common superscript letter differ significantly (p ≤ 0.05). 
1 TCON: basal diet; TTHY: basal diet supplemented with 3.7 mmol thymol/kg DM; TTαG: basal diet 
supplemented with 3.7 mmol thymol-α-D-glucopyranoside/kg DM; n = 12. 2 SI1, SI2, and SI3 
correspond to segments of 0%–25%, 25%–75%, and 75%–100% of the total small intestinal length, 
respectively. 3 Welch correction used. Calculated means are displayed. 4 Kruskal-Wallis non-
parametric test. Calculated means are displayed. 
The lack of statistical significance is probably due to the low number of replicates (n = 6) for 
performance parameters. This was, however, not the focus of our study. Besides, Trevisi et al. (2007) 
[43] reported a reduced ADFI in piglets supplemented with 10,000 mg thymol/kg due to the negative 
impact of this high dose on the palatability. Still, our results showed no differences in feed intake 
between treatments, indicating that piglets had no aversion towards pure or glycosylated thymol. 
Similarly, Anderson et al. (2012) [46] and Michiels et al. (2010) [44] described no alterations in the feed 
intake at low (67–201 mg/kg) and fairly high (500–2000 mg/kg) thymol doses, respectively. 
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Even though no significant improvements in growth performance were demonstrated in the 
current study, thymol supplementation did result in firmer feces and tended (p = 0.086) to reduce the 
diarrhea incidence in comparison to control piglets. This could indicate a beneficial modulation of 
the intestinal microbiota, although microbial metabolites were unaffected in the small and large 
intestines. Unfortunately, no compositional analysis was performed for the colon. Otherwise, 
improved fecal scores potentially relate to the improved barrier function in the small intestine, which 
might indicate a reduced inflammatory status of thymol-supplemented pigs [47]. 
4.2. Effects of TαG Supplementation on Thymol Concentrations in the Proximal GI Tract 
The suitability of EOs or their compounds as feed additives also depends on their stability 
during feed processing and storage [48]. In the current study, there was quite a large difference 
between the intended dose (3.7 mmol/kg DM) and the analytically verified concentrations in the feed, 
with recoveries of 65% and 81% for thymol and TαG, respectively. This discrepancy might have been 
due to the volatility of thymol; hence, evaporation might have taken place while mixing it into the 
feed [9]. This would also explain the higher recovery of TαG, as gluco-conjugation reduces the 
volatility of phenolics. Next, thymol and other EO compounds might absorb hydrophobic 
components in the feed, which not only reduces their antimicrobial activity [49] but also makes it 
harder to recover them from the complex feed matrix. However, the recovery rates of thymol and 
TαG from the feed matrix of the applied extraction method were verified for different concentrations 
and ranged between 101% and 122% [19]. Although the final feed concentrations were considerably 
lower than expected, the concentrations were still manifold higher than the concentrations of 
commercial products currently applied in animal feeds [50]. 
It was demonstrated by Michiels et al. (2008) [12] that, upon ingestion, thymol is quickly 
absorbed in the stomach and the proximal small intestine. Indeed, in-feed supplementation of thymol 
at 500 or 2000 mg/kg for 12 days yielded roughly four times lower concentrations (expressed as mg/kg 
fresh digesta) at the level of the stomach [44]. This is in agreement with our current results, taking 
into account the analytically verified thymol concentration in the feed (325 mg/kg feed) and a mean 
thymol concentration in the stomach contents of 96 ± 6.2 mg/kg fresh digesta in thymol-treated 
piglets. However, we preferred to express our results on a molar and dry matter basis; the latter to 
rule out the dilution effect of consumed water and the mixing with digestive juices. Then, the thymol 
concentration was only 13% lower in the stomach than in the feed. Still, from the duodenum on, 
thymol levels were no longer detectable, indicating a very quick disappearance from the intestinal 
lumen. Next, gluco-conjugation was examined as a protective measure against fast absorption, as was 
suggested by Petrujkić et al. (2013) [18]. In their ex vivo experiments conducted with TβG in everted 
porcine jejunal segments, the gluco-conjugate was absorbed 2.3 to 2.8 times less efficiently as 
compared to free thymol [18]. Unfortunately, our data could not confirm these findings. On the 
contrary, TαG supplementation led to 15% lower total thymol concentrations in the stomach contents 
than the addition of pure thymol. Additionally, more than half of the TαG in the stomach was already 
hydrolyzed into free thymol, and no detectable levels of either active compounds could be 
demonstrated in the small and large intestinal contents of TTαG animals. These results are in agreement 
with our previous experiment, where piglets were only supplemented for one day [19]. Still, it 
remains to be elucidated whether thymol glucosides can be absorbed through the gastric wall or if 
prior hydrolysis is required. Some flavonoid glycosides, such as those of quercetin [51] and daidzein 
[52], are not absorbed intact from the stomach, while anthocynanins (glyco-conjugated 
anthocyanidins) can cross the gastric wall [53]. In any case, linking thymol with one glucose unit did 
not result in higher luminal thymol concentrations in the distal small intestine, suggesting that 
conjugation with more complex sugars or longer sugar chains would be opportune. Indeed, Cermak 
et al. (2003) [54] demonstrated that metabolites of rutin, the glucorhamnoside of quercetin, appeared 
2 h later in the blood of pigs than those of the monoglucoside after oral administration, indicating 
delayed absorption. Nevertheless, in our case, the absorbed thymol might still have an advantageous 
effect via the systemic route. Moreover, the monoterpene might exert a topical action on the epithelial 
mucosa, as thymol has been shown to accumulate on the mucosal tissues [20,21].  
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4.3. Effects of Thymol and TαG Supplementation on the Intestinal Barrier Function 
Under healthy conditions, the intestinal epithelium functions as a selective barrier that inhibits 
the permeation of pathogens and antigens into the mucosal tissues, while allowing the passage of 
beneficial molecules like nutrients, ions, and water [55]. Tight junction (TJ) proteins are crucial to 
maintaining the barrier function, as they link adjacent epithelial cells on the apical side, thus 
controlling the paracellular transport route in a dynamic way [7,55]. Essential oils can regulate the 
barrier function by acting upon the gene expression and synthesis of TJ proteins [7]. Indeed, it was 
demonstrated in vitro that pretreatment of IPEC-J2 cells with thymol (50 μM) could alleviate the 
negative effects of lipopolysaccharide-induced damage to the barrier function by increasing the trans-
epithelial electrical resistance and reducing the FD4 flux [47]. Likewise, pigs fed a diet with oregano 
EO (25 mg/kg) during 4 weeks showed higher jejunal expression levels of the TJ proteins occludin 
and zonula occludens-1 and had longer villi, implying an improved intestinal integrity [56]. In 
agreement with these findings, our data also suggest an enhanced barrier function in the distal 
jejunum of thymol- but not TαG-supplemented piglets. This was apparent from the decreased FD4 
flux and the tendency for an increased VH:CD ratio in the TTHY treatment. The transcellular 
absorption route, however, was not affected, as can be seen from the unaltered HRP flux. It remains 
unclear why the gluco-conjugated form of thymol was unable to strengthen the GI integrity, 
especially because the luminal concentrations of both thymol and TαG in the distal jejunum were too 
low (<10 mg/kg) to be reliably detected with the current analytical method. Still, the effective thymol 
concentration needed to enhance the barrier function might be below our detection limit, as Omonijo 
et al. (2019) [47] found already increased TEER values at only 50 μM or 7.5 mg/kg.  
4.4. Effects of Thymol and TαG Supplementation on Gut Microbiota 
The application of thymol in pig feeds, in pure form or as a blend, has shown varying degrees 
of success with regard to the modulation of gut microbiota ([42,44–46,56,57]. In our study, the 
supplementation of thymol or TαG had no effect on the bacterial counts or their metabolites in the 
distal small intestine. Similarly, the bacterial metabolites in the mid-colon were unaltered. The lack 
of microbiota-modulating effects in the distal GI tract is probably due to the fact that the trace 
amounts of the active compounds (<10 mg/kg) remaining in those compartments were far below the 
required MICs for commensals and pathogens [10,11]. However, in the proximal small intestine, the 
E. coli counts were almost one log10 CFU/g lower in thymol- than in TαG-treated pigs, although the 
active compounds were no longer quantifiable in this compartment as well. It is supposed that the 
thymol supply from the stomach must have been sufficiently high to exert its antimicrobial action 
against E.coli before being absorbed, whether or not in combination with a potential topical action of 
thymol adhered to the mucosa. Furthermore, the lack of antimicrobial effects in the proximal small 
intestine following TαG supplementation might be caused by several factors. First, the supply of free 
and/or conjugated thymol from the stomach into the duodenum was potentially too low, especially 
when compared with the levels of active compounds retained in the stomach of thymol-fed piglets. 
Next, upon arrival of TαG in the duodenum, the presence of the sodium-dependent glucose 
transporter 1 (SGLT1) might facilitate the fast absorption of the intact gluco-conjugate [58]. 
Eventually, the glucosidase capacity in the duodenum might have been insufficient to hydrolyze TαG 
at an adequate rate into thymol plus glucose. Indeed, gluco-conjugation impairs the antimicrobial 
action of thymol, and hydrolysis by intestinal bacteria [59,60] or brush border enzymes like lactase 
phlorezin hydrolase [58] is necessary to release the bactericidal aglycon. 
Furthermore, a bacterial population analysis of the distal small intestine using 16S rRNA 
profiling was unable to highlight any diet-induced differences in the microbiome in the current study. 
Likewise, Li et al. (2018) [61] did not find differences in bacterial diversity or richness indices in the 
colon after supplementation of a carvacrol-thymol blend. However, these authors did find a shift in 
the relative abundance at the phylum level from Bacteroidetes to Firmicutes in the colonic contents 
of EO-supplemented piglets [61]. The contrast with our results is probably due to the difference in 
gut location and the extremely high relative abundance of Firmicutes (>98%) in the control group, not 
leaving much space for an additional increase in relative numbers. Indeed, clear differences exist 
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between the microbial communities of the small and large intestine. The jejunum and ileum show a 
lower bacterial diversity and an enrichment of Firmicutes relative to the large intestinal contents [62] 
and feces [63]. Proteobacteria was the second most abundant phylum in our samples, after Firmicutes. 
This observation is largely in agreement with the literature, although the reported relative 
abundances of these phyla fluctuate with values roughly ranging between 60% and 95% for 
Firmicutes and between 2% and 30% for Proteobacteria [62–65]. A variety of factors might explain 
the discrepancy between studies, such as differences in diets, antimicrobial use, age of the animals, 
breed, and environment [34]. Looft et al. (2014) [62] ascribed the difference between ileal and colonic 
microbiota to the dominance of Anaerobacter and Turicibacter in the ileum. However, these genera 
were hardly detected in our samples, while the most abundant genus was undoubtedly Lactobacillus 
(>97%). This is in agreement with the results of Argüello et al. (2018) [63] who found Lactobacillus 
levels of about 60% in 5 week-old piglets. Lactobacilli might have been stimulated by the lactose 
present in the diet (4%), as these bacteria are able to use the simple milk sugar for their energy 
production [66]. Finally, in agreement with our findings, L. amylovorus-like phenotypes were reported 
to be an abundant member of the ileal lactobacillus community [67,68]. Their presence is considered 
beneficial because of its antimicrobial activity against enteric pathogens [69]. In conclusion, 
notwithstanding that the desired modulating effect on the microbiota was absent, the 
supplementation of weaned piglets with thymol or TαG did not cause dysbiosis in the distal small 
intestine. 
4.5. Effects of Thymol and TαG Supplementation on the Glycosidase Activity in Mucosa 
Several studies have demonstrated the potential of EOs to enhance nutrient digestibility by 
promoting digestive secretions [6]. Digestibility was mainly increased for dry matter, proteins, and 
amino-acids, rather than for starch [70–72]. Although EO supplementation did increase the activities 
of pancreatic α-amylase and intestinal maltase in broiler chickens [73], we demonstrated an inhibitory 
effect of thymol supplementation on the βGLU and βGAL activity in the duodenal mucosa of piglets, 
which might interfere with the digestion of dietary sugars, like lactose, or other glucosides present in 
the diet, e.g., genistein or daidzin from soybeans [74]. Gluco-conjugation weakened the suppressive 
effect of thymol. In vitro studies have demonstrated the competitive inhibition of αGLU and βGAL 
by phytogenic compounds like isoquercitrin [75], carvacrol [76], and thymol [77]. However, further 
research is warranted to elucidate the mechanisms by which thymol inhibits glycosidase activity in 
vivo, as the literature data on this specific aspect are very limited.  
5. Conclusions 
Although the gluco-conjugate was designed to delay the absorption of thymol, TαG 
supplementation did not result in higher thymol concentrations in the gut of weaned piglets. Luminal 
concentrations in the stomach were even lower than with the addition of free thymol. Additionally, 
thymol-treated animals suffered less from diarrhea, showed an improved jejunal barrier function, 
and reduced mucosal β-glycosidase activities in the duodenum when compared to control piglets. 
Conversely, gluco-conjugation reduced the biological effects of thymol in vivo. It can be concluded 
that the conjugation of thymol into a single glucose molecule was insufficient to obtain the desired 
antimicrobial effect in the small intestine. 
Supplementary Materials: The following are available online at www.mdpi.com/xxx/s1, Figure S1: Schematic 
overview of the allocation; Figure S2: Bacterial community compositions present in the digesta of the last 25% of 
the small intestinal length for each individual pig. The cumulated histograms show the relative abundance of 
the identified taxa at the (a) phylum, (b) family, and (c) genus levels. 
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